Utility of serological screening for measles, mumps and rubella in immunocompromised patients
Marchi et al. in their article (Measles in pregnancy: a threat for Italian women? Hum Vaccin Immunother. 2019 Jun 20:1–3) observed that 96.9% of pregnant women were positive for anti-measles IgG (with a higher risk of contracting measles in those aged 19–29 years) emphasizing the importance of serol...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2019-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2019.1657353 |
| _version_ | 1797677379085139968 |
|---|---|
| author | L Sticchi M. Astengo I.G. Iavarone G. Icardi |
| author_facet | L Sticchi M. Astengo I.G. Iavarone G. Icardi |
| author_sort | L Sticchi |
| collection | DOAJ |
| description | Marchi et al. in their article (Measles in pregnancy: a threat for Italian women? Hum Vaccin Immunother. 2019 Jun 20:1–3) observed that 96.9% of pregnant women were positive for anti-measles IgG (with a higher risk of contracting measles in those aged 19–29 years) emphasizing the importance of serological screening before pregnancy. We evaluated seroprotection/seropositivity rates to Measles, Mumps and Rubella in 324 adults with an acquired immune-deficiency needing an immunization program. We found that younger patients (20–29 years) had a seroprevalence below 85%. Overall, a relevant proportion (21.6%, 54/250) of patients was susceptible to at least one infection needing immunization. Our results confirm the usefulness of proper strategies for identifying individuals susceptible to vaccine-preventable infections and protecting them through vaccination. |
| first_indexed | 2024-03-11T22:44:13Z |
| format | Article |
| id | doaj.art-ea7edf75ffe74ce786133c89c8d568d8 |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T22:44:13Z |
| publishDate | 2019-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-ea7edf75ffe74ce786133c89c8d568d82023-09-22T08:45:33ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2019-12-0115122854285510.1080/21645515.2019.16573531657353Utility of serological screening for measles, mumps and rubella in immunocompromised patientsL Sticchi0M. Astengo1I.G. Iavarone2G. Icardi3University of GenoaUniversity of GenoaUniversity of GenoaUniversity of GenoaMarchi et al. in their article (Measles in pregnancy: a threat for Italian women? Hum Vaccin Immunother. 2019 Jun 20:1–3) observed that 96.9% of pregnant women were positive for anti-measles IgG (with a higher risk of contracting measles in those aged 19–29 years) emphasizing the importance of serological screening before pregnancy. We evaluated seroprotection/seropositivity rates to Measles, Mumps and Rubella in 324 adults with an acquired immune-deficiency needing an immunization program. We found that younger patients (20–29 years) had a seroprevalence below 85%. Overall, a relevant proportion (21.6%, 54/250) of patients was susceptible to at least one infection needing immunization. Our results confirm the usefulness of proper strategies for identifying individuals susceptible to vaccine-preventable infections and protecting them through vaccination.http://dx.doi.org/10.1080/21645515.2019.1657353measlesmumpsrubellavaccinationitaly |
| spellingShingle | L Sticchi M. Astengo I.G. Iavarone G. Icardi Utility of serological screening for measles, mumps and rubella in immunocompromised patients Human Vaccines & Immunotherapeutics measles mumps rubella vaccination italy |
| title | Utility of serological screening for measles, mumps and rubella in immunocompromised patients |
| title_full | Utility of serological screening for measles, mumps and rubella in immunocompromised patients |
| title_fullStr | Utility of serological screening for measles, mumps and rubella in immunocompromised patients |
| title_full_unstemmed | Utility of serological screening for measles, mumps and rubella in immunocompromised patients |
| title_short | Utility of serological screening for measles, mumps and rubella in immunocompromised patients |
| title_sort | utility of serological screening for measles mumps and rubella in immunocompromised patients |
| topic | measles mumps rubella vaccination italy |
| url | http://dx.doi.org/10.1080/21645515.2019.1657353 |
| work_keys_str_mv | AT lsticchi utilityofserologicalscreeningformeaslesmumpsandrubellainimmunocompromisedpatients AT mastengo utilityofserologicalscreeningformeaslesmumpsandrubellainimmunocompromisedpatients AT igiavarone utilityofserologicalscreeningformeaslesmumpsandrubellainimmunocompromisedpatients AT gicardi utilityofserologicalscreeningformeaslesmumpsandrubellainimmunocompromisedpatients |